Grapefruit-Mavacamten Interaction Leading to Reduced Ejection Fraction
Trevor T Lovell, Jennifer Ogrin, Ahmad Elashery · 2026
Read Grapefruit-Mavacamten Interaction Leading to Reduced Ejection Fraction by Trevor T Lovell, Jennifer Ogrin, Ahmad Elashery (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13554913.txt.
Description
Trevor T Lovell, Jennifer Ogrin, and Ahmad Elashery report a grapefruit clash that weakened a heart drug's safety in a 2026 case report. Their fifty-seven-year-old patient took mavacamten for a thickened, obstructed heart muscle. Over months the drug eased the obstruction while pumping strength held steady. Then he began drinking grapefruit energy drinks daily.
About two months later his pumping strength had slipped to a reduced range. Grapefruit blocks a liver enzyme that clears the drug, so levels likely climbed too high. Stopping both the drug and the drinks restored his heart strength. Restarting the drug alone, without grapefruit, caused no repeat fall. The authors warn that hidden diet clashes can push this narrow-window drug into harm.
Catalog record
| CREATOR | Trevor T Lovell, Jennifer Ogrin, Ahmad Elashery |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17726 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |